Suppr超能文献

增殖性糖尿病视网膜病变患者玻璃体液中的游离胰岛素样生长因子-I和血管内皮生长因子

Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.

作者信息

Simó Rafael, Lecube Albert, Segura Rosa M, García Arumí José, Hernández Cristina

机构信息

Division of Endocrinology, Diabetes Research Unit, Hospital General Universitari Vall d'Hebron, Barcelona, Spain.

出版信息

Am J Ophthalmol. 2002 Sep;134(3):376-82. doi: 10.1016/s0002-9394(02)01538-6.

Abstract

PURPOSE

To investigate the relationship between insulin-like growth factor-I (IGF-I) and vascular endothelial growth factor (VEGF) in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy (PDR).

DESIGN

Observational case-control study.

METHODS

In a prospective study, 37 consecutive diabetic patients with PDR (14 type I and 23 type II diabetes mellitus) in whom a vitrectomy was performed were compared with 21 nondiabetic patients with other conditions requiring vitrectomy (control group). Free IGF-I and VEGF were measured by ELISA.

RESULTS

Vitreal levels of both free IGF-1 and VEGF were higher in diabetic patients with PDR than in control subjects (P <.01, and P <.0001, respectively). After adjusting for total intravitreous protein concentration, VEGF (ng/mg of proteins) remained significantly higher in diabetic patients with PDR than in the control group (P <.0001), whereas free IGF-I (ng/mg of proteins) was lower in diabetic patients than in control subjects (P <.0001). The vitreous concentrations of VEGF were higher in patients with active PDR than in patients with quiescent PDR (P <.005), whereas vitreous free IGF-I was not related to PDR activity. Finally, we did not observe a correlation between the vitreal levels of free IGF-I and VEGF.

CONCLUSIONS

We conclude that free IGF-I and VEGF are both increased, but not related, within the vitreous fluid of diabetic patients with PDR. In addition, our results support the current concept that VEGF is directly involved in the pathogenesis of PDR, whereas the precise role of free IGF-I remains to be established.

摘要

目的

探讨增殖性糖尿病视网膜病变(PDR)糖尿病患者玻璃体液中胰岛素样生长因子-I(IGF-I)与血管内皮生长因子(VEGF)之间的关系。

设计

观察性病例对照研究。

方法

在一项前瞻性研究中,将37例连续接受玻璃体切除术的PDR糖尿病患者(14例I型糖尿病和23例II型糖尿病)与21例因其他情况需要接受玻璃体切除术的非糖尿病患者(对照组)进行比较。采用酶联免疫吸附测定法(ELISA)检测游离IGF-I和VEGF。

结果

PDR糖尿病患者的玻璃体内游离IGF-1和VEGF水平均高于对照组(分别为P <.01和P <.0001)。调整玻璃体内总蛋白浓度后,PDR糖尿病患者的VEGF(每毫克蛋白中的纳克数)仍显著高于对照组(P <.0001),而糖尿病患者的游离IGF-I(每毫克蛋白中的纳克数)低于对照组(P <.0001)。活动期PDR患者的玻璃体内VEGF浓度高于静止期PDR患者(P <.005),而玻璃体内游离IGF-I与PDR活动无关。最后,我们未观察到游离IGF-I与VEGF的玻璃体内水平之间存在相关性。

结论

我们得出结论,PDR糖尿病患者的玻璃体液中游离IGF-I和VEGF均升高,但两者无相关性。此外,我们的结果支持当前的观点,即VEGF直接参与PDR的发病机制,而游离IGF-I的确切作用仍有待确定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验